Delivery Order SPE2DB20D9331-SPE2DB24FL1H9
Award Date
7/3/24
Potential Completion Date
7/25/24
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order valued at $4,974.08, issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract provides for the delivery of STELARA 130 MG/26 ML VIAL 26ML, a biologic medication. The order is placed under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a...
This firm-fixed price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on July 1, 2024. The $4,974.08 contract is for the supply of a STELARA 130 MG/26 ML VIAL 26ML pharmaceutical product. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the SPE2DB program administered by the Defense Logistics Agency (DLA). The contract, valued at $3,730.56, is for the delivery of STELARA 130 mg/26 ml vials to support the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,611.25 firm fixed-price delivery order is for the supply of the drug STELARA 90 MG/ML SYRINGEML. The award is not a set-aside contract. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,243.52 firm fixed-price delivery order is for the supply of STELARA 130 MG/26 ML VIAL 26ML, and is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, to provide a 130 mg/26 ml vial of the drug Stelara. The contract has a potential value of $1,243.52 and a completion date of March 20, 2024. This delivery order is part of a larger indefinite delivery contract (contract 4600082013) between DMS Pharmaceutical Group and DLA, valued at up to $4,999,999 through the end of 2025, which...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of 130 mg/26 ml vials of the drug Stelara. The $3,730.56 firm fixed-price delivery order was awarded on October 23, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 14, 2024. The award is not associated with any set-aside designations. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,730.56, is for the delivery of STELARA 130 MG/26 ML VIAL 26ML, a specialty pharmaceutical product. The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,059.74 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes. The award is not associated with any set-aside designation. The contract is part of DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $16,441.36 and is a firm fixed-price delivery order with a period of performance ending on March 21, 2025. This award is part of a larger indefinite delivery contract (IDC) that DMS...